TC 527 - Early detection and organised testing in US and Europe

The session will discuss the evolution of diagnostic pathway and role of MRI in improving the detection and localisation of life-threatening prostate cancer. It aims to describe the MRI-pathway for early detection of prostate cancer based on the North American and European guidelines and discuss how practice patterns of MR-informed prostate biopsy may differ between the US and Europe. The attendee will learn about the basis for the European screening recommendations from the Europe Union's Beating Cancer Plan. Furthermore, the challenges and controversies of prostate cancer screening vs early detection, based on guidelines (EAU/AUA/NCCN), will be discussed.